Printer Friendly

EMPI ANNOUNCES 1991 SALES AND INCOME RECORDS, AS ANNUAL NET INCOME MORE THAN DOUBLES

 EMPI ANNOUNCES 1991 SALES AND INCOME RECORDS,
 AS ANNUAL NET INCOME MORE THAN DOUBLES
 ST. PAUL, Minn., Feb. 18 /PRNewswire/ -- Empi, Inc. (NASDAQ: EMPI), a medical device manufacturer, today announced record sales and net income for the fourth quarter and full year 1991.
 For the fiscal year ended Dec. 31, 1991, sales were up 36 percent to $21.8 million, compared with $16.0 million in 1990. Net income more than doubled from the previous year to reach $2.0 million, or $.59 per share, up 126 percent from $903,000, or $.31 per share, in 1990. Net income for 1991 includes a non-recurring fourth-quarter charge to earnings of $.02 per share, due to prepayment of a term loan.
 For the 1991 fourth quarter, sales rose 45 percent to $6.5 million from $4.5 million in 1990. Net income for the quarter was $784,000, or $.20 per share, a 206 percent increase from $256,000, or $.09 per share, during the same period in 1990.
 Mike Connoy, Empi president and chief operating officer, said: "In virtually every way, 1991 was a remarkable year for Empi. Continued expansion of our sales force resulted in dramatically improved sales. The increasingly efficient operation of many of the sales territories we've added over the past two years, together with the gross margin improvement from higher production levels, has had an even greater impact on earnings.
 "Other important 1991 developments included regulatory clearance for two new proprietary products -- our Innova(TM) female urinary incontinence treatment system and our Dupel(TM) iontophoresis system for non-invasive drug delivery through the skin," Connoy said. "In October, we completed a secondary stock offering to provide resources to market these products."
 Sales training programs for Innova and Dupel were completed this month, and a nationwide market launch is under way for both products. Innova will be sold by Empi's existing sales representatives and several specialists to obstetricians, gynecologists and urogynecologists. Dupel is targeted to the rehabilitation market, including Empi's current customer base.
 Empi develops, manufactures and distributes non-invasive biomedical devices and accessories for electro-therapeutic applications in physical medicine, orthopedic, rehabilitation and neurology markets. The company's shares are traded on the NASDAQ national market system under the symbol EMPI.
 EMPI, INC.
 CONDENSED STATEMENTS OF OPERATIONS
 Three Months Ended
 December 31, Pct.
 1991 1990 Change
 Net Sales $6,476,197 $4,472,047 + 45
 Cost of Sales and Expenses 5,201,712 4,105,947 + 27
 Income Before Income Tax 1,274,485 366,100 +248
 Income tax 490,500 110,100
 Net Income $ 783,985 $ 256,000 +206
 Net Income per Common Share $ .20 $ .09 +122
 Weighted Average Shares
 Outstanding 4,008,474 2,903,184
 Twelve Months Ended
 December 31, Pct.
 1991 1990 Change
 Net Sales $21,818,547 $16,027,973 + 36
 Cost of Sales and Expenses 18,564,591 14,651,375 + 27
 Income Before Income Tax 3,253,956 1,376,598 +136
 Income tax 1,213,000 474,000
 Net Income $ 2,040,956 $ 902,598 +126
 Net Income per Common Share $ .59 $ .31 + 90
 Weighted Average Shares
 Outstanding 3,464,975 2,888,110
 -0- 02/18/92
 /CONTACT: Timothy Briggs of Empi 612-639-2330, or Diane Rose or Marian Briggs of Padilla Speer Beardsley, 612-871-8877, for Empi/
 (EMPI) CO: Empi, Inc. ST: Minnesota IN: MTC SU: ERN


KH -- MN005 -- 9815 02/18/92 10:08 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 18, 1992
Words:563
Previous Article:A.T. MASSEY COAL COMPANY SUBSIDIARIES ACQUIRE OCCIDENTAL COAL PROPERTIES
Next Article:MERIDIAN RECEIVES OUTSTANDING RATING FOR COMMUNITY REINVESTMENT EFFORTS
Topics:


Related Articles
EMPI RESPONDS TO STOCK ACTIVITY
EMPI REPORTS STRONG FIRST-QUARTER SALES AND EARNINGS GAINS
EMPI ANNOUNCES STRONG GAINS IN SECOND-QUARTER SALES, EARNINGS
EMPI REPORTS STRONG GROWTH IN THIRD-QUARTER SALES, NET INCOME
EMPI, INC. ANNOUNCES MANAGEMENT CHANGES
EMPI SALES, NET INCOME SET RECORDS FOR 1992 FOURTH QUARTER AND FULL YEAR
EMPI REPORTS RECORD RESULTS FOR SECOND QUARTER AND FIRST HALF
EMPI ANNOUNCES RECORD SALES AND NET INCOME FOR 1993 FOURTH QUARTER AND FULL YEAR
EMPI ANNOUNCES FINANCIAL RESULTS FOR 1994 FOURTH QUARTER AND FULL YEAR
EMPI ANNOUNCES FINANCIAL RESULTS FOR 1995 FOURTH QUARTER AND FULL YEAR

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters